Turka Laurence A. 4
4 · Rubius Therapeutics, Inc. · Filed Feb 3, 2020
Insider Transaction Report
Form 4
Turka Laurence A.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-31+350,000→ 350,000 totalExercise: $7.80Exp: 2030-01-30→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on January 21, 2021, then in 12 equal quarterly installments thereafter.